Methods: We used data from 9951 Medicare beneficiaries 65 years and above in the Reasons for Geographic And Racial Differences in Stroke study. Between 2003 and 2012, 669 participants had an MI identified and adjudicated through study procedures (ie, the gold standard), and 552 had an overnight inpatient claim with a code for MI (ICD-9 code 410.x0 or 410.x1) in any discharge diagnosis position.
in the context of other conditions, including heart failure and tachyarrhythmia, which may be the main cause of hospitalization. 10 Type 4-5 MIs occur in patients undergoing a coronary revascularization. Therefore, type 2 and 4-5 MIs may be less likely to be identified using claims databases compared with type 1 MIs if only the main cause of hospitalization is recorded.
There are few data available on the validity of using claims for MI identification in the era with highly sensitive biomarkers available. There are also few data on whether estimations of MI risk and exposure-MI associations are similar using primary data collection, claims data, and primary data collection supplemented by claims data. Using claims data may have low sensitivity for MI identification and underestimate MI risk. However, if the positive predictive value (PPV) is high and estimates of exposure-MI associations are similar using claims data and primary data collection, this would support using either approach to study risk factors for MI.
METHODS
The Reasons for Geographic And Racial Differences in Stroke (REGARDS) study enrolled a population-based cohort of 30,239 black and white men and women 45 years of age and above from all 48 contiguous US states and the District of Columbia between January 2003 and October 2007. 11 RE-GARDS study participant data were combined with claims from Medicare, a US government health insurance program for adults 65 years of age and above, and younger adults who are disabled or have end-stage renal disease. 12 For the current analysis, we excluded 15,278 REGARDS study participants younger than 65 years of age as younger adults with Medicare coverage represent a select subpopulation who are disabled or have end-stage renal disease. We further excluded 2835 participants without data linked to Medicare, 2082 participants without inpatient fee-for-service coverage and 93 participants without REGARDS study follow-up for MI. Medicare inpatient fee-for-service coverage was defined as having Medicare Part A coverage without Medicare Advantage (a capitated program which does not require submitting claims for reimbursement). After these exclusions were applied, data for 9951 REGARDS study participants were analyzed (Supplemental Fig. 1 , Supplemental Digital Content 1, http://links.lww.com/MLR/B629). The RE-GARDS study was approved by the Institutional Review Boards governing research in human subjects at the participating centers and all participants provided written informed consent, including for the analysis of their Medicare claims.
Baseline Assessment
Baseline data collection in the REGARDS study occurred through a telephone interview administered by trained staff and an in-home examination by health professionals. 11 Data collected at baseline were used to define participant characteristics, including age, race, sex, geographic region of residence, education, total annual household income, current smoking, diabetes, hypertension, history of coronary heart disease (CHD), statin use, elevated C-reactive protein (CRP), chronic kidney disease, and cognitive impairment. Definitions for participant characteristics are provided in Supplemental 
Identification of MIs
In the REGARDS study, participants or their proxies are contacted biannually to identify suspected CHD events and deaths. 13 Medical records are retrieved for suspected CHD-related hospitalizations. When deaths are identified, interviews with proxies are conducted, and records for hospitalizations in the last year of life, death certificates, and autopsy reports are retrieved. During adjudication, 2 clinicians independently classified each event as not being an MI, or being a possible, probable or definite MI, following published guidelines. 7, 9, 14, 15 Only definite or probable events were considered MIs in the REGARDS study. Definite or probable MIs with a peak troponin level <0.5 μg/L were classified as "microsize" MIs. 8 Definite or probable MIs were subsequently classified into types following the Universal Definition and on whether they occurred in-hospital versus out-of-hospital. 9 We identified overnight inpatient claims with a discharge diagnosis code for MI [ie, an International Classification of Diseases, ninth revision (ICD-9) diagnosis code of 410.x0 or 410.x1] in any discharge diagnosis position. We further identified the subgroup of overnight inpatient claims with a discharge diagnosis code for MI in the primary position as this represents the main reason for hospitalization. 16 Medicare inpatient claims with a discharge diagnosis code for MI in any position were adjudicated as described above for events identified through REGARDS study procedures. For the current study, definite or probable MIs identified through REGARDS study procedures or Medicare claims, and Medicare claims with a discharge diagnosis code for MI in any position were available through December 31, 2012.
Statistical Analysis
We calculated characteristics of participants included in the analysis. The validity of Medicare claims for MI identification was assessed using sensitivity and PPV, following the Centers for Disease Control and Prevention guidelines for evaluating surveillance systems. 17 Sensitivity was calculated as the proportion of definite or probable MIs identified and adjudicated through REGARDS study procedures which had a claim for MI in Medicare. The calculation of sensitivity was restricted to participants who had Medicare inpatient fee-forservice coverage on the date of the definite or probable MI adjudicated in the REGARDS study. For participants having multiple definite or probable MI during follow-up, only the first event was used to calculate sensitivity. PPV was calculated as the proportion of Medicare claims for MI which were classified as a definite or probable MI through REGARDS study procedures. The calculation of PPV was restricted to Medicare claims whose adjudication was completed. For participants having multiple Medicare claims for MI, only the first claim was used to calculate PPV. Sensitivity and PPV were calculated for the full population, and in subgroups defined by age, sex, race, region of residence, calendar year of the event, education, income, cognitive impairment and history of CHD. Sensitivity was also calculated for microsize MIs versus other MIs, type of MIs, and MIs occurring in-hospital versus out-of-hospital. PPV was not calculated by MI characteristics because there are no specific ICD-9 diagnosis codes for microsize MI or type of MI. We compared sensitivity and PPV across subgroups using χ 2 tests or Fisher exact tests, as appropriate. In secondary analyses, sensitivity was calculated after excluding MIs in the last year of life, including adjudicated MIs identified through REGARDS study procedures or through Medicare claims, including recurrent MIs from participants with multiple events during follow-up, and including MIs from participants without Medicare inpatient fee-for-service coverage on the date of their MI (Supplemental Methods, Supplemental Digital Content 1, http:// links.lww.com/MLR/B629). In secondary analyses, PPV was calculated after excluding Medicare claims in the last year of life, and including all MI claims for participants with multiple events. To determine whether MIs identified and adjudicated through REGARDS study procedures were not billed to Medicare, we calculated the proportion of events included in the main analysis of sensitivity which did not have an inpatient claim for any reason in Medicare. Calculations were repeated in subgroups defined by age, sex, race, region of residence, calendar year of the event, education, income, cognitive impairment, and history of CHD.
We calculated the cumulative incidence by the KaplanMeier method and rates of MI using 5 definitions: (1) REGARDS: first definite or probable MI identified and adjudicated through REGARDS study procedures. Participants not having this event were censored on their death date, first day with unknown vital status in REGARDS (ie, the day of the last study contact with the participant), or December 31, 2012, whichever occurred first. (2) REGARDS-Medicare any : first event identified through REGARDS study procedures or through Medicare claims with a discharge diagnosis code for MI in any position which was subsequently classified as a definite or probable MI in REGARDS. Participants not having this event were censored on their death date, first day with unknown vital status in REGARDS and without Medicare inpatient fee-for-service coverage, or December 31, 2012, whichever occurred first. Rate ratios (RRs) and 95% confidence intervals (CIs) comparing MI rates using the 5 definitions listed above were calculated using bootstrapping with 1000 random samples with replacement and the bias-corrected percentile method. 18 We used Cox regression models to calculate multivariableadjusted hazard ratios (HR) for MI using each of the 5 definitions listed above associated with age, sex, race, region of residence, education, income, smoking, diabetes, hypertension, history of CHD, statin use, elevated CRP, chronic kidney disease, and cognitive impairment, overall and among participants with and without a history of CHD. The statistical significance of differences in HRs for MI definitions was calculated using bootstrapping with 1000 random samples with replacement and the bias-corrected percentile method. 18 Chained equations were used to obtain 50 multiple imputed datasets in Stata 13 (Stata Corp, College Station, TX) to retain participants with missing data (Supplemental Table 2 , Supplemental Digital Content 1, http://links.lww.com/MLR/ B629) in the regression models. 19, 20 All analyses were conducted using a 2-sided level of significance <0.05.
RESULTS
The mean age of participants was 72.6 years, 50.0% were male and 32.8% were black (Table 1) . Overall, 669 participants had a definite or probable MI identified and adjudicated through REGARDS study procedures, including 596 who had Medicare inpatient fee-for-service coverage on In total, 552 participants had a Medicare claim with a code for MI in any discharge diagnosis position, including 523 (94.7%) for whom the adjudication has been completed. Also, 411 participants had a Medicare claim with a code for MI in the primary discharge diagnosis position, including 398 (96.8%) for whom the adjudication has been completed. The PPV of Medicare claims with a code for MI in any and in the primary discharge diagnosis position was 84.3% (95% CI, 80.9%-87.3%) and 89.7% (95% CI, 86.3%-92.5%), respectively (Table 3) . PPV was not statistically significantly different across levels of age, sex, race, region of residence, calendar year, education, income, and cognitive impairment, but was lower among participants with versus without a history of CHD. Compared with the primary analysis, the PPV was higher after excluding Medicare claims in the last year of life (Supplemental Fig. 3 , Supplemental Digital Content 1, http://links.lww.com/MLR/B629).
Overall, 55 (9.2%) of the 596 definite or probable MIs included in the main analysis of sensitivity did not have an inpatient claim in Medicare. The proportion of MIs without an inpatient claim in Medicare was similar across subgroups defined by participant characteristics, except for sex (Supplemental Table 3 , Supplemental Digital Content 1, http://links. lww.com/MLR/B629). The proportion of MIs without a Medicare inpatient claim was higher among men versus women.
Risk for MI
The cumulative incidence for MI was higher when definite or probable MIs identified and adjudicated through RE-GARDS study procedures (REGARDS definition) were Table 4 , middle and bottom panels, respectively. The HR for MI among men compared with women was lower using the Medicare any versus the REGARDS definition (Fig. 1 , left panel and Supplemental Table 5 , Supplemental Digital Content 1, http://links.lww.com/MLR/B629). The HR associated with low income was higher using the Medicare any and Medicare primary versus the REGARDS definition. Also, the HR associated with elevated CRP was lower using the REGARDS-Medicare primary versus the REGARDS definition. HRs for MI associated with the remaining participant characteristics were not statistically significantly different when using each MI definition. HRs for MI associated with participant characteristics among participants with and without a history of CHD, separately are shown in Figure 1 
DISCUSSION
In the current analysis, Medicare claims with a discharge diagnosis code for MI had high PPV but low sensitivity for MI identification, using REGARDS study adjudication procedures as the gold standard. Using Medicare claims to supplement MIs identified and adjudicated through REGARDS study procedures detected additional MI cases and resulted in a modestly higher MI rate. In contrast, using Medicare claims with a discharge diagnosis code for MI without further adjudication underestimated the MI rate compared with REGARDS study procedures. Most associations of participant characteristics with MI were similar when events were defined using REGARDS study procedures, REGARDS study procedures supplemented with MIs identified through Medicare claims, and Medicare claims without further adjudication.
In a prior study of Medicare beneficiaries in Pennsylvania in 1999-2000, the PPV of Medicare inpatient claims with an ICD-9 discharge diagnosis code of 410.x1 in the primary position for MI identification was 95.1% (95% CI, 94.1%-96.2%). 21 In the Cardiovascular Health Study (CHS), which enrolled Medicare beneficiaries, the PPV of hospital records with an ICD-9 discharge diagnosis code of 410.x1 in any and in the primary position from baseline in 1989-1993 through 2012 was 84.7% and 90.6%, respectively. 22 Results from the current study are consistent with a high PPV of Medicare claims for MI identification. Taken together, these studies suggest that Medicare claims for MI likely represent an MI that occurred.
In the CHS, sensitivity of hospital records with an ICD-9 discharge diagnosis code of 410.x1 in any and in the primary position was 70.4% and 53.8%, respectively. 22 In the A total of 182 REGARDS study participants had missing data on history of coronary heart disease (Supplemental Table 2 23, 24 Having VA benefits may also explain the lower sensitivity of Medicare claims for MI among men versus women in the current analysis. Medicare uses a prospective payment system through which reimburses hospitalizations with a fixed amount determined based on the primary reason for hospitalization. 25 Therefore, MIs occurring in-hospital, including type 2 and 4-5 MIs, could be less likely to be present in claims versus medical records as they may not change the reimbursement amount. CHS started before (baseline 1989-1993), while the RE-GARDS study started after (baseline 2003-2007), highly sensitive biomarkers were recommended for the diagnosis of MI in 2000. 6 Therefore, the proportion of microsize MIs identified and adjudicated in the REGARDS study may be higher as compared with CHS. Studies relying on participant or proxy reports to initiate the MI adjudication process may not identify all events and, therefore, may underestimate MI risk. In the Women's Health Initiative (WHI), which relies on participant or proxy reports for MI identification, supplementing study procedures with Medicare claims with a discharge diagnosis code for MI in any position without adjudication resulted in a 33% increase in the number of participants identified as having an MI. 26 In the 
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Definitions of MI § FIGURE 1. Hazard ratios for myocardial infarction associated with participant characteristics. *A total of 182 REGARDS study participants had missing data on history of coronary heart disease (Supplemental Table 2 , Supplemental Digital Content 1, http:// links.lww.com/MLR/B629).
current analysis, including events identified through Medicare claims with a discharge diagnosis code for MI in any and in the primary position which were subsequently adjudicated as definite or probable MIs increased the MI rate by 12% and 6%, respectively, compared with using the REGARDS study procedures alone. Results from the current study also suggest that Medicare claims may underestimate the risk for MI when used as the sole data source for event identification. Medicare claims with a discharge diagnosis code for MI in any position may be preferred to estimate MI rates as they have higher sensitivity while maintaining high PPV as compared with Medicare claims with a discharge diagnosis code for MI in the primary position.
In the WHI hormone therapy trial, HRs for MI associated with hormone replacement versus placebo were similar using MIs defined through study adjudication procedures and through Medicare claims without adjudication. 26 In the CHS, the association of age, sex, race, blood pressure, smoking, and diabetes with MI was similar using MIs defined through study adjudication procedures and through hospital records without adjudication. 22 Results from the current study expand on these data by showing that HRs for MI associated with many participant characteristics were similar using study procedures, study procedures supplemented with MIs identified through Medicare claims, and Medicare claims without further adjudication.
The current analysis has known and potential limitations. CHD-related hospitalizations were adjudicated using data available in medical records. Therefore, some Medicare claims may have been misclassified as not being a definite or probable MI due to medical records being incomplete, resulting in an underestimation of the PPV. We restricted the analyses to REGARDS study participants 65 years of age and above. Therefore, results may not be generalizable to adults younger than 65 years of age. Having VA benefits or other health insurance programs may contribute to the low sensitivity of Medicare claims for MI identification. However, data from the VA or other health insurance programs were not available in the current analysis. Although the REGARDS study collected MI data from a nationwide, diverse group of hospitals, data on hospital characteristics were not available for the current analysis. Therefore, we were unable to compare the validity of Medicare claims for MI across subgroups defined by hospital characteristics. Finally, many REGARDS study participants were missing data on at least one baseline characteristic, which required the used of multiple imputation to include them in regression models.
In conclusion, Medicare claims have high PPV but low sensitivity for identifying MIs. The sensitivity of Medicare claims for MI identification varied by sex and MI characteristics. Also, using Medicare claims as the only data source underestimates the risk for MI. Despite these limitations, results from the current study supports using primary data collection, claims data, or primary data collection supplemented by claims data to investigate individual-level risk factors for MI.
